WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Site License Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

U.S. Neurotherapeutics Markets

Frost & Sullivan, November 1997



Landmark discoveries in the neurosciences are revolutionizing our understanding of the human brain and its chemical structure. This report from Frost & Sullivan covers new drugs designed to treat such diverse brain disorders as multiple sclerosis, ALS, Alzheimer s dementia, and stroke, as well as treatments for more mature markets. Competitive strategies, such as rereleasing new formulations of existing products, are discussed at length. And profiles for companies like Glaxo-Wellcome, Warner-Lambert, and Parke-Davis are included.



- Executive Summary

- The Richest Pipeline in the Industry

- Summary of Major Findings

- Conclusions

- Industry Challenges and Research Methodology

- Challenges Facing the Pharmaceutical Industry

- Time Frame Analysis of Industry Challenges

Customers who bought this item also bought